home / stock / hypr / hypr news


HYPR News and Press, Hyperfine Inc. From 03/30/22

Stock Information

Company Name: Hyperfine Inc.
Stock Symbol: HYPR
Market: NASDAQ
Website: hyperfine.io

Menu

HYPR HYPR Quote HYPR Short HYPR News HYPR Articles HYPR Message Board
Get HYPR Alerts

News, Short Squeeze, Breakout and More Instantly...

HYPR - Hyperfine, Inc. 2021 Q4 - Results - Earnings Call Presentation

The following slide deck was published by Hyperfine, Inc. in conjunction with their 2021 Q4 earnings call. For further details see: Hyperfine, Inc. 2021 Q4 - Results - Earnings Call Presentation

HYPR - Hyperfine, Inc.'s (HYPR) CEO Dave Scott on Q4 2021 Results - Earnings Call Transcript

Hyperfine, Inc. (HYPR) Q4 2021 Earnings Conference Call March 23, 2022 4:30 P.M. ET Company Participants Dave Scott - President and Chief Executive Officer Alok Gupta - Chief Financial Officer Conference Call Participants Vijay Kumar - Evercore ISI Anthony Petrone - Mizuho Group Presentation ...

HYPR - Hyperfine GAAP EPS of -$2.73, revenue of $0.44M

Hyperfine press release (NASDAQ:HYPR): Q4 GAAP EPS of -$2.73. Revenue of $0.44M (+109.5% Y/Y). Cash and cash equivalents totaled $188.498 million as of December 31, 2021. For further details see: Hyperfine GAAP EPS of -$2.73, revenue of $0.44M

HYPR - Hyperfine Reports Fourth Quarter and Full Year 2021 Financial Results

GUILFORD, Conn., March 23, 2022 (GLOBE NEWSWIRE) -- Hyperfine (Nasdaq: HYPR), the groundbreaking medical device company that created Swoop®, the world's first FDA-cleared portable MRI system™, today announced fourth quarter and full year 2021 financial results and provided a bus...

HYPR - Hyperfine: MR Imaging In A Swoop

Hyperfine has developed the world’s first portable MRI system that can acquire images from a patient’s bedside. The Company is founded by serial inventor, Dr. Jonathan Rothberg. The Company recently consummated a business combination and has filed S-1 for the resale ...

HYPR - Hyperfine to Announce Fourth Quarter and Full Year 2021 Financial Results

GUILFORD, CT, March 03, 2022 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the creator of Swoop®, the world's first FDA-cleared portable MRI system™, today announced that it will report financial results for the fourth quarter and full year 2021 on Wednesday, March 23,...

HYPR - Hyperfine to Present at the 42nd Annual Cowen Healthcare Conference

GUILFORD, Conn., March 01, 2022 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the creator of Swoop®, the first FDA-cleared portable magnetic resonance imaging (MRI) system™, today announced that the company will be participating in the upcoming 42 nd Annual Co...

HYPR - Queen's University Radiology Receives Hyperfine Portable MRI to Improve Access to Care for Canadian Patients in Remote Northern Communities

GUILFORD, Conn. and MOOSE FACTORY, Ontario, Feb. 16, 2022 (GLOBE NEWSWIRE) -- Hyperfine, Inc . (Nasdaq:HYPR), creator of Swoop®, the first FDA-cleared portable magnetic resonance imaging (MRI) system™, is proud to announce that Queen's University and Kingston Health Scie...

HYPR - Hyperfine Appoints Chip Truwit, M.D. as Senior Medical Director

GUILFORD, Conn., Feb. 08, 2022 (GLOBE NEWSWIRE) -- Hyperfine Inc. (Nasdaq:HYPR), creator of Swoop®, the first FDA-cleared portable magnetic resonance imaging (MRI) system™, today announced the appointment of Dr. Chip Truwit as senior medical director. For more than 30 years, Tru...

HYPR - Palisade Bio, Pharming lead healthcare gainers; LogicBio Therapeutics, Pardes among losers

Gainers: Palisade Bio (NASDAQ:PALI) +23%. Pharming Group (NASDAQ:PHAR) +14%. Entasis Therapeutics (NASDAQ:ETTX) +13%. Epizyme (NASDAQ:EPZM) +11%. IceCure Medical (NASDAQ:ICCM) +10%. Losers: LogicBio Therapeutics (NASDAQ:LOGC) -50%. Pardes Bios...

Previous 10 Next 10